1-4 of 4
Roger Pak
Close
Sort by
Journal Articles

Inhibition of heat shock protein 90 prolongs survival of mice with BCR-ABL-T315I–induced leukemia and suppresses leukemic stem cells

Cong Peng, Julia Brain, Yiguo Hu, Ami Goodrich, Linghong Kong, David Grayzel, Roger Pak, Margaret Read, Shaoguang Li
Journal: Blood
Blood (2007) 110 (2): 678–685.
https://doi.org/10.1182/blood-2006-10-054098
Published: 2007
Journal Articles

IPI-504, a Novel, Orally Active HSP90 Inhibitor, Prolongs Survival of Mice with BCR-ABL T315I CML and B-ALL.

Cong Peng, MS, Julia Brain, PhD, Yiguo Hu, MD, Linghong Kong, MD, PhD, David Grayzel, MD, Roger Pak, PhD, Margaret Read, PhD, Shaoguang Li, MD, PhD
Journal: Blood
Blood (2006) 108 (11): 2183.
https://doi.org/10.1182/blood.V108.11.2183.2183
Published: 2006
Journal Articles

Hsp-90 Inhibition Decreases Survival of BCR-ABL T315I Leukemic Stem Cells in Mice.

Cong Peng, MS, Julia Brain, PhD, Yiguo Hu, MD, Linghong Kong, MD, PhD, Ami Goodrich, David Grayzel, MD, Roger Pak, PhD, Margaret Read, PhD, Shaoguang Li, MD, PhD
Journal: Blood
Blood (2006) 108 (11): 2184.
https://doi.org/10.1182/blood.V108.11.2184.2184
Published: 2006
Journal Articles

Anti-Tumor Activity of IPI-504, a Novel Hsp90 Inhibitor in Multiple Myeloma.

Vito J. Palombella, Ph.D., Emmanuel Normant, Ph.D., Janid Ali, Ph.D., John Barrett, Ph.D., Michael Foley, Ph.D., Yun Gao, Ph.D., Jennie Ge, Ph.D., Asimina T. Georges, Ph.D., David Grayzel, M.D., Louis Grenier, Jebecka Hudak, Roger Pak, Ph.D., Jon Patterson, Christine Pien, Melissa Pink, James Porter, Ph.D., Junbiao Sang, Kerry Spear, Ph.D., Jens Sydor, Ph.D., Jim Wright, Ph.D., Constantine S. Mitsiades, M.D., Kenneth C. Anderson, M.D., Julian Adams, Ph.D., Jeffrey Tong, Ph.D.
Journal: Blood
Blood (2004) 104 (11): 4922.
https://doi.org/10.1182/blood.V104.11.4922.4922
Published: 2004